Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromsø Staph and Skin Study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 4, 2012, Pages 465-473

  Olsen, K ^a,b   Falch, B M ^a   Danielsen, K ^a,b   Johannessen, M ^b   Ericson Sollid, J U ^b   Thune, I ^b,c   Grimnes, G ^a,b   Jorde, R ^a,b   Simonsen, G S ^a,b   Furberg, A S ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM DETECTION; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE; NOSE SMEAR; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; STAPHYLOCOCCUS AUREUS; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NOSE; RISK FACTORS; SEX FACTORS; SMOKING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VITAMIN D;

EID: 84862837778     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1331-x     Document Type: Article

References (40)

1. ECDC (2009) European antimicrobial resistance surveillance system (EARSS). European Centre for Disease Prevention and Control
2. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van dT I, van Belkum A, Verbrugh HA, Vos MC (2010) Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 362:9-17
3. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344:11-16 (Pubitemid 32064839)
4. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5:751-762 (Pubitemid 41688980)
5. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA (2009) Coevolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9:32-47
6. Nouwen J, Ott A, Boelens H et al (2004) Smoking pattern and fasting glucose levels determine Staphylococcus aureus nasal carriage. Erasmus University Medical Centre, Rotterdam, The Netherlands. PhD thesis
7. Wang JT, Liao CH, Fang CT, Chie WC, Lai MS, Lauderdale TL, Lee WS, Huang JH, Chang SC (2009) Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol 47:2957-2963
8. Choi CS, Yin CS, Bakar AA, Sakewi Z, Naing NN, Jamal F, Othman N (2006) Nasal carriage of Staphylococcus aureus among healthy adults. J Microbiol Immunol Infect 39:458-464 (Pubitemid 46374211)
9. Matheson EM, Mainous AG III, Hueston WJ, Diaz VA, Everett CJ (2010) Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage. Scand J Infect Dis 42:455-460
10. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL (2006) Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118:509-519 (Pubitemid 44079569)
11. Schauber J, Gallo RL (2008) The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol 17:633-639 (Pubitemid 352044354)
12. White JH (2010) Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol 121:234-238
13. Pearce SH, Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340:b5664
14. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18-28 (Pubitemid 44699167)
15. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E (2006) Epidemic influenza and vitamin D. Epidemiol Infect 134:1129-1140 (Pubitemid 44614932)
16. Chesney RW (2010) Vitamin D and the magic mountain: the anti-infectious role of the vitamin. J Pediatr 156:698-703
17. Ginde AA, Mansbach JM, Camargo CA Jr (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169:384-390
18. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, Ylikomi T (2007) An association of serum vitamin D concentrations<40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86:714-717 (Pubitemid 47435839)
19. Grimnes G, Almaas B, Eggen AE, Emaus N, Figenschau Y, Hopstock LA, Hutchinson MS, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol 163:339-348
20. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171:903-908
21. Olsen K, Simonsen GS, Sundsfjord A, Haukland HH, Sollid JE, Danielsen K, Haldorsen B, Eggen AE, Furberg AS (2009) The epidemiology of Staphylococcus aureus nasal and throat carriage in a large community-based population in Northern Norway. The Tromsø Staph and Skin Study. Poster number 1678 at the 19th ECCMID (19th European conference of clinical microbiology and infectious diseases), Helsinki
22. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I (2011) Cohort profile: the Tromsø Study. Int J Epidemiol 1-7. doi:10.1093/ije/dyr049
23. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF (2009) Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 199:1820-1826
24. Leino A, Turpeinen U, Koskinen P (2008) Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 analyzer. Clin Chem 54:2059-2062 (Pubitemid 352774041)
25. Marriott I, Huet-Hudson YM (2006) Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34:177-192 (Pubitemid 44195935)
26. Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3:97-104 (Pubitemid 38854894)
27. Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, Saleh M (2009) Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci USA 106:9016-9020
28. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42:2206-2214 (Pubitemid 28420351)
29. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317-322 (Pubitemid 40194499)
30. Lips P (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90:611-614 (Pubitemid 38844358)
31. Youssef D, Bailey B, El Abbassi A, Copeland R, Adebonojo L, Manning T, Peiris AN (2010) Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect 138:1322-1327
32. Beery TA (2003) Sex differences in infection and sepsis. Crit Care Nurs Clin North Am 15:55-62 (Pubitemid 38608985)
33. Ford ES, Zhao G, Tsai J, Li C (2011) Association between concentrations of vitamin D and concentrations of insulin, glucose, and HbA1c among adolescents in the United States. Diabetes Care:1-3. doi:10.2337/dc10-1754
34. Knekt P, Laaksonen M, Mattila C, Harkanen T, Marniemi J, Heliovaara M, Rissanen H, Montonen J, Reunanen A (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19:666-671
35. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 202:809-814
36. Nnoaham KE, Clarke A (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113-119 (Pubitemid 351228619)
37. Nielsen NO, Skifte T, Andersson M, Wohlfahrt J, Soborg B, Koch A, Melbye M, Ladefoged K (2010) Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 104:1487-1491
38. Claassen M, Nouwen J, Fang Y, Ott A, Verbrugh H, Hofman A, van Belkum A, Uitterlinden A (2005) Staphylococcus aureus nasal carriage is not associated with known polymorphism in the Vitamin D receptor gene. FEMS Immunol Med Microbiol 43:173-176 (Pubitemid 40170286)
39. Panierakis C, Goulielmos G, Mamoulakis D, Maraki S, Papavasiliou E, Galanakis E (2009) Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes. Int J Infect Dis 13:e437-e443
40. Haldorsen B, Olsen K, Ericson Sollid J, Husom Haukland H, Sundsfjord A, Simonsen G, Breivik S, Larsen G, Furberg AS (2009) Nasal and throat swab cultures for the assessment of Staphylococcus aureus colonization and carriage. The Tromsø Staph and Skin Study. Poster number 1150 at the 19th ECCMID (19th European conference of clinical microbiology and infectious diseases), Helsinki